SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-289404
Filing Date
2019-11-12
Accepted
2019-11-12 08:59:02
Documents
3
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d770487d8k.htm 8-K 18702
2 EX-99.1 d770487dex991.htm EX-99.1 69077
3 GRAPHIC g770487g91o64.jpg GRAPHIC 21049
  Complete submission text file 0001193125-19-289404.txt   117995
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36352 | Film No.: 191206449
SIC: 2834 Pharmaceutical Preparations